Sign in
4/A

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-054743

Options or other derivatives

  • Director acquired 28,394 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sigal Charles Elliott Director 2020-07-10 Grant or award · Stock Option (Right to Buy) +28,394 28,394 D: show line 1 in the form
Loading xslF345X03/doc4a.xml…